2021 Fall Conference | Industry Therapeutic Update from Novartis: KESIMPTA: Flexibility of a Self-Administered RMS Therapy

Date Friday 11/05/21

Time 11:30 AM - 12:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Industry Therapeutic Update

Director(s) David Hojnacki, MD, FAAN

Topic(s)

CME Available No CME available

Event Timeline
11:30 AM - 12:00 PM EDT	Speaker	Industry Therapeutic Update from Novartis: KESIMPTA: Flexibility of a Self-Administered RMS Therapy

Faculty Disclosures
David Hojnacki, MD, FAAN	Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.

��ɫ����